A journal retracted a linkurl:2004 paper;http://www.ncbi.nlm.nih.gov/pubmed/15301984?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum this week that was among the 70,000 papers linkurl:flagged last week;http://www.the-scientist.com/blog/display/54210/ as potentially containing plagiarized material. Last week's report, published in Nature, presented findings from a new text-search program that scanned medical literature for duplicate publication. The retracted paper was one of 70 that the researchers noted as highly suspicious. The journal Best Practices & Research: Clinical Rheumatology, said in a statement to the Boston Globe that linkurl:it had retracted;http://www.boston.com/news/health/blog/2008/01/british_journal_1.html a 2004 paper by Lee S. Simon that reviewed treatments for rheumatoid arthritis, which contained text from a linkurl:2003 article;http://www.ncbi.nlm.nih.gov/pubmed/12904092?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum in Expert Opinion: Drug Safety by Roy Fleischmann at the University of Texas Southwestern Medical Center at Dallas. Simon declined to comment to the Globe, and spokespeople for Harvard Medical School and Beth Israel Deaconess Medical Center, where Simon is based, said they were investigating. According to the Chronicle of Higher...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?